About Invion
Invion is a clinical-stage life-sciences company that holds the Australia and New Zealand license to the PhotosoftTM technology for the treatment of all cancers. Research and clinical trials are funded by the technology licensor, The Cho Group, which will provide non-dilutive funding to the Company. Invion is listed on ASX (ASX:IVX).
Ann: Photosoft efficiently destroys ovarian cancer cells in vitro, page-20
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.12M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $75.25K | 15.05M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 21400000 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 11518431 | 1 |
View Market Depth
| Last trade - 12.00pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 606667 | ||
| Last updated 11.45am 27/05/2024 ? | |||||
| IVX (ASX) Chart |